A recent webcast with an international panel of experts and featuring real world data and case studies provided insights into the practical use of baricitinib for rheumatoid arthritis and ixekizumab for psoriatic arthritis. The webcast was sponsored by Eli Lilly, and the discussion was moderated by Professor Bruce Kirkman, Professor of Translational Rheumatology at King’s ...
The practical use of baricitinib and ixekizumab reflected in real world data and case studies
19 May 2021
Sponsored by Eli Lilly Australia Pty Ltd